Power Wheelchair Group 3 denied for failing step therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for power wheelchair group3 are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Applies Step Therapy to Power Wheelchair (Group 3)

Step therapy — sometimes called "fail-first" — in the power-mobility context means UHC requires documentation that you have tried and failed lesser mobility solutions before approving a Group 3 complex rehabilitation technology (CRT) power wheelchair. Specifically, UHC's coverage policy typically requires evidence that a manual wheelchair, a standard power wheelchair (Group 1 or Group 2), or other assistive mobility device was trialed and found clinically inadequate. The denial fires when that trial history is absent from the submitted documentation, even if such a trial was clinically inappropriate for your diagnosis.

This is one of the most commonly reversed denial types for Group 3 power wheelchairs because many patients with complex neurological or progressive diagnoses are not clinically appropriate candidates for lower-level devices — and the policy itself typically contains an exception for medical contraindication to step therapy.

## Your Federal Appeal Rights

Under ACA §2719, you are entitled to independent external review after exhausting internal appeals. Under ERISA §503 (self-funded plans), you have the right to full-and-fair review. The external-review window is generally approximately four months from the denial notice. Many states also have step-therapy exception laws requiring insurers to waive step requirements when a lower-level device is medically contraindicated or has previously failed — confirm whether your state has such a law.

Request expedited review if the absence of the device creates an urgent health or safety risk.

## Documentation to Gather

• Trial history (if it exists): physician or therapist notes documenting any prior trial of a manual wheelchair or lower-group power wheelchair, including dates, specific inadequacies observed, and clinical outcomes.
• Clinical contraindication to step therapy (if applicable): if a lower-level device was never appropriate for your diagnosis, your prescribing physician and ATP should explicitly document why — this satisfies the medical-exception pathway in most policies without requiring a failed trial.
• Diagnosis and functional assessment: detailed records establishing your primary diagnosis, its severity, and the functional impairments that make the Group 3 device specifically necessary (e.g., complex postural needs, upper extremity weakness, progressive neurological involvement).
• UHC's coverage policy: identify the exact step-therapy language and the exception criteria (medical contraindication, prior failure, clinical progression).

## Criteria-Mapping Structure

Address each step-therapy requirement and the applicable exception:

| Step-Therapy Requirement | Documentation Provided | |---|---| | Trial of manual wheelchair | [Trial notes with dates and outcomes, OR contraindication letter] | | Trial of Group 1/2 power wheelchair | [Trial notes with dates and outcomes, OR contraindication letter] | | Medical exception to step requirement | [Physician letter citing diagnosis; ATP evaluation; policy exception language] |

Pairing the exception language directly from UHC's published policy with clinical documentation addressing each element is the most effective structure for this appeal.